Concepedia

Publication | Closed Access

Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial

74

Citations

28

References

2023

Year

Abstract

The MRDs were successfully assessed using FCM. An MTX dose of 2 g/m<sup>2</sup> was effective in preventing relapse in non-HR pcB-ALL. Augmented IB showed no advantages over the standard IB.[Media: see text].

References

YearCitations

Page 1